What better video to post the day before International CML Awareness Day from the man that gave us all hope and continues to push the boundaries of treatment. Thank you Doctor Druker. Kris

Dr. Brian Druker, a CML expert from OHSU’s Knight Cancer Institute and a key researcher responsible for the development of imatinib, gives his perspective about the progress that’s been made in research and treatment.  He is encouraged that, in most cases, patients can have their disease well managed on existing therapies, while newer agents–some still in trials–will provide even more options for those who are resistant or are experiencing side effects.  Dr. Druker explains that he believes CML research can, and should, begin focusing on eradicating the disease altogther, and provides his suggestion about how he believes that might happen.